The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.

Hammond, Edward; Khurana, Ashwani; Shridhar, Viji; Dredge, Keith

Hammond, Edward; Khurana, Ashwani; Shridhar, Viji; Dredge, Keith.

Afiliación

Hammond E; Progen Pharmaceuticals Ltd. , Brisbane, QLD , Australia.
Khurana A; Department of Experimental Pathology, Mayo Clinic College of Medicine , Rochester, MN , USA.
Shridhar V; Department of Experimental Pathology, Mayo Clinic College of Medicine , Rochester, MN , USA.
Dredge K; Progen Pharmaceuticals Ltd. , Brisbane, QLD , Australia.

Front Oncol ; 4: 195, 2014.

Article en En | MEDLINE | ID: mdl-25105093

Palabras clave

Sulf1; Sulf2; cancer therapy; heparan sulfate; heparanase; tumor microenvironment targeting

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2014 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2014 Tipo del documento: Article País de afiliación: Australia